Safety and Efficacy of Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Coexisting Medical Conditions: Final Results of the Run-in Phase of the Randomized CLL14 Trial (BO25323)
暂无分享,去创建一个
T. Kipps | M. Hallek | J. Dongen | S. Stilgenbauer | A. Langerak | S. Opat | M. Dreyling | C. Wendtner | R. Humerickhouse | M. Ritgen | C. Owen | M. Mobasher | V. Goede | J. Bahlo | E. Tausch | A. Fink | K. Fischer | S. Robinson | R. Weinkove | O. Al-Sawaf | B. Eichhorst | M. Dixon | K. Humphrey | Javier López | S. Boettcher | S. Warburton | Stephen Samuel Opat